ClinicalTrials.Veeva

Menu

Multiprofessional Approach in Diabetes Mellitus

L

Leonardo Paroche de Matos

Status

Unknown

Conditions

Diabetes Mellitus, Type 2

Treatments

Behavioral: Specific and educational guidelines on care for pathology (diabetes mellitus) according to each profession involved in the research

Study type

Interventional

Funder types

Other

Identifiers

NCT04958980
00129122020

Details and patient eligibility

About

OBJECTIVE: to verify the effectiveness of adopting the practice of educational groups in primary care and the multiprofessional role in the control of diabetes mellitus in adults. METHODOLOGY: a randomized clinical study carried out in an educational group at the Basic Health Unit Nova Bonsucesso with six monthly meetings scheduled with 24 patients with type II diabetes mellitus users of oral hypoglycemic agents divided into two subgroups: 12 users in the control group and 12 users in the control group. study (which will receive the interventions of the multidisciplinary team) and will be accompanied by laboratory tests and individual evaluations to verify the effectiveness of the multidisciplinary action in the control of diabetes mellitus.

Full description

INTRODUCTION: diabetes mellitus is highlighted as an obstacle in health equipment because it is a chronic disease and has a high mortality rate. The pathology results in hyperglycemia, disorders or insufficiency of several organs. OBJECTIVE: to verify the effectiveness of adopting the practice of educational groups in primary care and the multidisciplinary role in the control of diabetes mellitus in adults. THEORETICAL BACKGROUND: type II diabetes mellitus (type II DM) is a pathology that represents a high risk for cardiovascular, renal, ophthalmological complications and in several other systems. It is considered a major issue to be controlled by health services, as the high cost of treatments related to the sequelae of type II DM, as well as high rates of hospitalizations and associated therapies have been increasing and decompensating public budgets. Primary care has a fundamental role in preventing the disease and associated complications. METHODOLOGY: randomized clinical study conducted in an educational group at the Basic Health Unit Nova Bonsucesso with six monthly meetings scheduled with 24 patients with type II diabetes mellitus users of oral hypoglycemic agents divided into two subgroups: 12 users in the control group and 12 users in the group study (which will receive the interventions of the multidisciplinary team) and will be accompanied by laboratory tests and individual evaluations to verify the effectiveness of the multidisciplinary performance in the control of diabetes mellitus. RESULTS: the participants are expected to show improvements in the control of the pathology and awareness about the relevance of self-care, facts that will be observed through laboratory data and subsequent multi-professional evaluations.

Enrollment

24 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 24 on-insulin-dependent type II diabetes patients (users of oral hypoglycemic agents),
  • over 18 years of age,
  • both sexes,
  • with no restrictions on physical exercise (found after medical evaluation)
  • who agreed to participate voluntarily in the study (after signature of the Free and Informed Consent Form)
  • of a specific area of the Family Health Strategy - chosen by the proximity to the Basic Health Unit.

Exclusion criteria

  • Patients with associated pathologies: cardiovascular conditions: Congestive Heart Failure,Decompensated Systemic Arterial Hypertension, Sequela of Acute Myocardial Infarction
  • Cancer patients,
  • Respiratory conditions: Chronic Obstructive Pulmonary Disease, Severe asthma and any other disabling lung condition.
  • Endocrine conditions that aggravate diabetes mellitus: Pancreatic pathologies (pancreatitis, pancreatic cysts, obstructions and pancreatic cancer)
  • Patients with impaired vision,
  • Motor or balance disorders,
  • With any special needs (physical or intellectual),
  • With consequences resulting from the evolution of type II diabetes mellitus
  • Users who refused to participate in the research.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

24 participants in 2 patient groups

Placebo
No Intervention group
Description:
The control group will be evaluated in 2 stages: at the beginning and at the end of the study and will be accompanied only with scheduled medical consultations (also simulating the reality of basic health units with a traditional model of care) and the intervention group will undergo evaluations with the multiprofessional team on two occasions (at the beginning and at the end of the study)
Specific and educational guidelines on pathology care (diabetes mellitus)
Active Comparator group
Description:
Multiprofessional educational guidelines and analysis of the following exams: * Periodontal record, bleeding rate on and visible plaque; * Body mass index (BMI): weight (kg) divided by height squared (m²); * Serum glucose values; * Glycated hemoglobin; * Blood count: hemoglobin; * Urea: male: * Creatinine male; * Uric acid; * Oxalacetic glutamic transaminase; * Glutamic pyruvic transaminase; * Total cholesterol and fractions: Cholesterol, Non HDL, LDL, VLDL; * Triglycerides; * Type I urine; * Vitamin D3 25OH; * Microalbuminuria; * Blood pressure: systolic; * Abdominal circumference.
Treatment:
Behavioral: Specific and educational guidelines on care for pathology (diabetes mellitus) according to each profession involved in the research

Trial contacts and locations

0

Loading...

Central trial contact

Leonardo Matos

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems